Company

EuroProxima B.V has two private shareholders both of whom held for many years key positions in the management and development of the Euro-Diagnostica group. The management is supported by a dedicated and professional team that worked together for years. Now this group finds inspiration in concentrating all skills to the benefit of its own activities. The company operates from the same location with the same scientific and business contacts as it did for many years. This means we can maintain the same level of service and professionalism as we did for many years.

The Shareholders of the Company:

Drs Piet J.M. van Wichen is 55 years of age and lives with his wife and two children in Oss, The Netherlands.

After studying Biology at the University of Utrecht and receiving a Master degree in Cell biology, he specialized in Immunochemistry. Piet’s professional career started in the seventies at Organon, followed by a research function at the University Nijmegen, The Netherlands.

In 1985 Piet was appointed Product Manager of Euro-Diagnostica B.V. In 1992 Piet was promoted to General Manager of Euro-Diagnostica B.V. With the growth of the Euro-Diagnosticagroup, Piet concentrated on the Veterinary and Food-Safety Business. In 2005 a Bachelor degree in Export Marketing Management was obtained.

In the second half of 2008 he concluded, together with Mr. Paul de Römph, a Management Buy-Out of this Food-Safety Division and the name of the company was changed to EuroProxima B.V.

Mr. Paul de Römph is 49 years of age and lives with his wife and his three children in The Netherlands, nearby The Hague.

After completing his study of Economics in Rotterdam, Paul built up more than 25 years of experience in Finance and Management, acquired through high ranking management positions with such large international companies as IKEA, CODA-Financials and BAAN Company.

At the beginning of 1999 Paul was appointed CFO of an international pharmaceutical investment group, called C&P Investors Ltd. This Private Equity Fund was and is active through investments in (generic plus) pharmaceuticals, the peptide industry, real estate, venture capital (life sciences projects) and diagnostics (Food-Safety and Human).

Euro-Diagnostica B.V. formed part of the C&P investment group and this provided the connection between Piet and Paul, evolving in a long-standing professional relationship that resulted in their Managament Buy-Out of the Euro-Diagnostica B.V. Food-Safety Division from the C&P Group in the latter half of the year 2008.